Mucoepidermoid carcinoma (MEC) represents 10-15% of salivary neoplasms. Due to their
low incidence, it is challenging to conduct clinical trials and develop treatment guidelines …

Salivary gland carcinomas (SGC) are a rare and variable group of head and neck cancers
with historically poor response to cytotoxic chemotherapy and immunotherapy in the …

Salivary gland tumors (SGT) are a group of highly heterogeneous head and neck
malignancies with widely varied clinical outcomes and no standard effective treatments. The …

Salivary gland cancer (SGC) is a rare malignancy consisting of 22 subtypes with different
genetic, histological and clinical characteristics. This rarity and heterogeneity makes …

Simple Summary Salivary gland tumors are rare among both pediatric and adult
populations. Mucoepidermoid carcinoma (MEC) is a common type of malignant salivary …

Introduction: Salivary gland carcinomas (SGC) are histologically diverse cancers and next-
generation sequencing (NGS) to identify key molecular targets is an important aspect in the …

Mucoepidermoid carcinoma (MEC) is the most common malignancy of salivary glands. The
response of MEC to chemotherapy is unpredictable, and recent advances in cancer biology …

Background: Mucoepidermoid carcinoma (MEC) shows differences in biological behaviour
depending mainly on its histological grade. High-grade tumours usually have an aggressive …

Aims Mucoepidermoid carcinoma (MEC) is one of the most common salivary gland
carcinomas. Epidermal growth factor receptor (EGFR) signalling pathway gene mutations …

Abstract Background: Salivary gland cancers (SGCs) are a rare and heterogeneous group of
malignancies, accounting for approximately 5% of head and neck cancers. Despite their …